New method can improve drug delivery in implants

An innovative biomaterial discovery by researchers at the University of Toronto in collaboration with Ripple Therapeutics Inc., has established a method that yields better control over drug release profiles in implants and has the potential to disrupt the classical drug delivery market.

Ripple.png
university-of-toronto-vector-logo.png
Previous
Previous

Ripple Therapeutics Research on Polymer-Free Drug Delivery Published in Nature Communications

Next
Next

New Venture Ontario Fund Drives Economic Growth and Creation of High-Value Jobs